Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
about
Portuguese crypto-Jews: the genetic heritage of a complex historyModelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreA Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsGlucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.Parkinson disease in Gaucher disease.Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsElevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysisApplications of iPSC-derived models of Gaucher diseaseThe NINDS Parkinson's disease biomarkers program.Whole-Exome Sequencing in Familial Parkinson Disease.A molecular analysis of the GBA gene in Caucasian South Africans with Parkinson's disease.Genetic convergence of Parkinson's disease and lysosomal storage disorders.Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease.Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells.A Human Neural Crest Stem Cell-Derived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers.Impact of Parkinson's disease risk loci on age at onset.High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients.Parkinson's disease prevalence in Fabry disease: A survey study.Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.Patients' Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers.Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay.Cognition among individuals along a spectrum of increased risk for Parkinson's disease
P2860
Q28085453-FA7288E4-71EB-4E07-B6F2-BC2141D5FD12Q29048624-9AAFAD8A-E241-4C41-85A9-9385D0B4D8B8Q30235844-ED27B169-1B07-4AD5-897F-95DFCBB488A2Q30367337-C204C905-05B0-4645-99D6-6D3B1A2708B7Q30852543-42308651-A0F2-4665-BD85-06ED3EEE43C3Q36041420-2B08BFEA-3EB8-4757-B063-FE50EF25D440Q36284241-62949E42-F7BF-44BE-B69B-A1A952A966D3Q36352522-05DA711A-66D0-43D9-814E-0A5A34D01058Q36777618-7C531347-9AA0-4ED4-85DD-EE978143E1D5Q37098159-DFC8A486-777D-41D8-8836-60F6F7AF0D71Q37725826-DD308F29-C832-4972-83AA-17403C2F80F7Q38237560-99614D51-ED93-45C7-A418-04F36D06FC5EQ38605208-A2E5F071-A207-4EEB-8D06-1B466BFC8D6DQ38727638-DAEC868E-4E68-4B7A-A3B8-2E8143B572FDQ38808532-6B78DD48-2F73-4004-911B-D4F85B54B0ABQ39058736-236CCB0D-C25D-49F5-85DB-5CD008E33470Q40603461-1F23D478-D81A-43FB-B6F1-A4B7E77A37E2Q41926295-AF1149A9-30B5-428F-A3F8-CE8622086C27Q42226747-B0C1BB76-DFCF-41B9-A815-9A4F1AF5CC7FQ42315677-09E8701C-F4F8-4F08-ABA1-891155CB3800Q43673984-2DD77577-D394-4528-B0A3-53F130F196DAQ46264470-DF18F506-1261-410E-A1F0-FA7A5BA9301CQ47097659-F159BB60-C920-4A6A-9426-C921A51D6642Q47819345-54CA6272-7B55-44CE-8273-E612FF2EC7F7Q48191413-807A1373-5D17-4729-93A1-8041E64A36C4Q48266068-CD882D46-37F6-489D-B5CA-6EE4CC2E5C05Q50178933-413948EA-0EF2-4665-B275-D7A0812454B3Q57168544-530E8A61-16AC-4467-B4D2-1F08537713F5
P2860
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@ast
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@en
type
label
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@ast
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@en
prefLabel
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@ast
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@en
P2093
P2860
P1433
P1476
Comparison of Parkinson risk i ...... disease and GBA heterozygotes.
@en
P2093
Ari Zimran
Cheryl Waters
Deborah Elstein
Huma Q Rana
Karina Sakanaka
Louise Bier
Manisha Balwani
Michael Pauciulo
Roy N Alcalay
P2860
P304
P356
10.1001/JAMANEUROL.2014.313
P407
P50
P577
2014-06-01T00:00:00Z